Efficacy and Side Effects of Cyclosporine

Cyclosporine is an immunosuppressant and a disease-modifying antirheumatic drug (DMARD), primarily used in connective tissue disorders with significant hematologic involvement—such as rheumatoid arthritis, systemic lupus erythematosus (SLE), Sjögren’s syndrome, and mixed connective tissue disease. So, what are the therapeutic effects and adverse effects of cyclosporine? Below, we provide a detailed explanation.

Therapeutic Effects of Cyclosporine

Cyclosporine is primarily used to prevent organ transplant rejection. It is one of the most commonly employed immunosuppressants in clinical practice, especially for prophylaxis against rejection following solid-organ transplantation. It may also be used to treat graft-versus-host disease (GVHD) following allogeneic bone marrow or hematopoietic stem cell transplantation. Patients should carefully read the package insert prior to use to understand contraindications, precautions, potential adverse reactions, dosing instructions, and administration guidelines. Regular follow-up visits and laboratory monitoring at the hospital—as directed by the physician—are essential to assess treatment response and adjust dosage accordingly. In patients with refractory autoimmune or rheumatic diseases—such as SLE or steroid-resistant nephrotic syndrome—cyclosporine may be considered when other immunosuppressants have failed.

Adverse Effects of Cyclosporine

1. Cyclosporine carries several well-documented adverse effects, among which nephrotoxicity is the most prominent. However, this renal toxicity is typically reversible and does not usually cause permanent kidney damage. Renal function generally improves upon dose reduction or discontinuation. Therefore, close monitoring of renal function—including serum creatinine and blood urea nitrogen (BUN)—is mandatory during therapy to guide timely dose adjustments or, if necessary, drug discontinuation.

2. Like other immunosuppressants, cyclosporine increases the risk of lymphoproliferative disorders and other malignancies—particularly skin cancers. Patients requiring long-term cyclosporine therapy should be counseled about the potential risk of cutaneous malignancies and undergo regular dermatologic surveillance.

3. Common side effects include hypertrichosis, gingival hyperplasia, gastrointestinal disturbances, paresthesia, headache, and tremor. These effects are often dose-dependent and typically diminish or resolve upon dose reduction or cessation of therapy.

4. Hypertension occurs in a subset of patients receiving cyclosporine. Blood pressure must therefore be closely monitored throughout treatment; caution is warranted in patients with preexisting hypertension.

The above outlines the principal therapeutic effects and adverse effects of cyclosporine. We hope this information proves helpful to you.